bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
All Web sites
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2013: M A M F J
2012: D N O S A J J M

 
  Other news for:
Acquired Immunodeficiency Syndrome
 Resources from HONselect
More Americans Get Effective HIV Treatment, Study Says
And they appear to be less infectious

By Robert Preidt

WEDNESDAY, Sept. 5 (HealthDay News) -- The percentage of HIV-infected people in the United States receiving highly active retroviral therapy has increased since 2000, according to a new study.

The researchers also found that people with HIV appear to be less infectious and have healthier immune systems at death.

Researchers looked at national data on 45,000 people receiving clinical care for infection with HIV, the virus that causes AIDS. Between 2000 and 2008, the proportion of HIV-infected people prescribed highly active retroviral therapy increased nine percentage points to 83 percent.

During that time, there was an increase in viral load suppression among HIV patients. Suppression of viral load reduces the likelihood of transmitting HIV to others. Among patients taking highly active retroviral therapy, the proportion with suppressed viral load increased from 54 percent to 81 percent between 2000 and 2008.

The researchers also found an increase in median CD4 immune cell count among patients who died from HIV. A higher CD4 count suggests a healthier immune system.

The study, published in the Sept. 4 issue of the journal Annals of Internal Medicine, was led by researchers at the Johns Hopkins University Bloomberg School of Public Health, in Baltimore.

The findings are "good news for the HIV epidemic in the U.S., but there is room for improvement," lead author Keri Althoff, an assistant professor in the Bloomberg School's department of epidemiology, said in a school news release. "We need to continue to focus on linking HIV-infected adults into care and effective treatment, not only for the individual's health, but to reduce the likelihood of transmission to others."

More information

The U.S. National Institute of Allergy and Infectious Diseases has more about HIV/AIDS.

SOURCE: Johns Hopkins University Bloomberg School of Public Health, news release, Sept. 3, 2012

Copyright © 2012 HealthDay. All rights reserved. URL:http://www.healthscout.com/template.asp?id=668330

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Therapeutics
Research Personnel
Acquired Immunodeficiency Syndrome
Viral Load
Immune System
Infection
Adult
Hypersensitivity
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact